Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

WIN site inhibition disrupts a subset of WDR5 function

Scientific Reports(2022)10.1038/s41598-022-05947-9Source: DataRank Database

WIN site inhibition disrupts a subset of WDR5 function is a research paper published in Scientific Reports (2022). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (32 grants)Impact (FWCI 2.51)OA: goldTopics (77)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Jing Wang ORCID,Andrea C. Florian ORCID,Lance R. Thomas ORCID,Joy H. Creighton,Brittany K. Matlock

Live enrichment

PubMed:35115608 PMC:PMC8813994 OpenAlex:https://openalex.org/W4210696656

National Cancer Institute

Grant: CA200709

National Cancer Institute

Grant: CA009582

National Cancer Institute

Grant: CA211305

National Cancer Institute

Grant: CA68485

National Cancer Center

Grant: CA257102

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK058404

NCI NIH HHS

Grant: P30 CA068485

NCI NIH HHS

Grant: P50 CA236733

NCI NIH HHS

Grant: R50 CA211305

NCI NIH HHS

Grant: F31 CA257102

NCI NIH HHS

Grant: T32 CA119925

NCRR NIH HHS

Grant: UL1 RR024975

NCRR NIH HHS

Grant: G20 RR030956

NCI NIH HHS

Grant: HHSN261200800001E

NEI NIH HHS

Grant: P30 EY008126

NCI NIH HHS

Grant: R01 CA200709

CCR NIH HHS

Grant: HHSN261200800001C

NIDDK NIH HHS

Grant: P30 DK058404

NCI NIH HHS

Grant: T32 CA009582

National Institutes of Health

Grant: 3P30CA068485-23S2

Cancer Center Support Grant

National Institutes of Health

Grant: 1F31CA257102-01

The Utility of WDR5 WIN Site Inhibitors in Rhabdoid Tumors

National Institutes of Health

Grant: 1G20RR030956-01

VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced Genomics

National Institutes of Health

Grant: 3UL1RR024975-03S4

The Vanderbilt Institute for Clinical and Translational Research (VICTR) UL1

National Institutes of Health

Grant: 5P30EY008126-08

CORE--ILLUSTRATION AND PHOTOGRAPHY MODULE

National Institutes of Health

Grant: 5R01CA200709-04

Facilitated recruitment of MYC to chromatin by interaction with WDR5

National Institutes of Health

Grant: 5T32CA009582-34

Biochemical and Chemical Training for Cancer Research

National Institutes of Health

Grant: 1P30DK058404-01A1

CORE--MICROARRAY

National Institutes of Health

Grant: 1R50CA211305-01A1

Myc, WDR5, and Cancer

National Institutes of Health

Grant: 1ZIADK013039-04

Molecular modeling of soluble proteins

National Institutes of Health

Grant: 5T32CA119925-10

Integrated Biological Systems Training in Oncology

Rally Foundation

Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

FWCI

2.51

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-022-05947-9.pdf

publisherhttps://www.nature.com/articles/s41598-022-05947-9.pdf

publisherhttps://www.nature.com/articles/s41598-022-05947-9

journalhttps://doi.org/10.1038/s41598-022-05947-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35115608

Fields of Study

Epigenetics and DNA MethylationCancer-related gene regulationGenomics and Chromatin Dynamics0301 basic medicine03 medical and health sciences0303 health sciencesAntineoplastic AgentsBinding SitesBridged Bicyclo Compounds, HeterocyclicCell CycleCell Line, TumorCell ProliferationChromatin Assembly and DisassemblyGene Expression Regulation, NeoplasticHistonesHumansIntracellular Signaling Peptides and ProteinsLymphoma, B-CellMethylationProtein BindingProtein Interaction Domains and MotifsProteolysisSignal TransductionTranscription, Genetic

MeSH Terms

Antineoplastic AgentsBinding SitesCell CycleHistonesHumansMethylationProtein BindingTranscription, GeneticSignal TransductionGene Expression Regulation, NeoplasticLymphoma, B-CellBridged Bicyclo Compounds, HeterocyclicChromatin Assembly and DisassemblyCell Line, TumorIntracellular Signaling Peptides and ProteinsCell ProliferationProtein Interaction Domains and MotifsProteolysis

Keywords

Small moleculeContext (archaeology)HistoneFunction (biology)Binding siteBiologyChromatinEpigeneticsComputational biologyCell biologyGeneticsGeneLymphoma, B-CellTranscription, GeneticScienceAntineoplastic AgentsMethylationArticleHistonesCell Line, TumorHumansProtein Interaction Domains and MotifsCell ProliferationBinding SitesQCell CycleRIntracellular Signaling Peptides and ProteinsBridged Bicyclo Compounds, HeterocyclicChromatin Assembly and DisassemblyGene Expression Regulation, NeoplasticProteolysisMedicineProtein BindingSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being